Supplementary
: Caspase3/7 activity and activated caspase 3 levels in MIA PaCa-2 cells treated with gemcitabine in combination with miR-29a. MIA PaCa-2 cells were transfected with CTRL or miR-29a mimics. A. Transfected cells were treated with 10μM gemcitabine (GEM) for 24 hours, lysed, and caspase activity was determined using Apo-ONE Homogeneous Caspase-3/7 Assay. Average fluorescence (490/530nm) are represented (n=4) ± S.E.M. B. Transfected cells were treated with 10μM GEM for 12 hours. Post GEM treatment, 15ug of total protein lysate was subjected to western blot analysis for pro-caspase 3 and cleaved caspase 3 quantification. GAPDH was used as loading control. Relative quantification of band intensities normalized to GAPDH are shown below respective blots.
Supplementary Figure S3: LDH release in MIA PaCa-2 cells treated with gemcitabine in combination with miR-29a.
MIA PaCa-2 cells were transfected with CTRL or miR-29a mimics, treated with gemcitabine (GEM) for 48 hours and lactate dehydrogenase (LDH) release was determined by substrate based activity assay (fluorescence 560/590nm). Average relative percent cytotoxicity are represented (n=4) ± S.E.M. A. MIA PaCa-2 or B. COLO 357 pancreatic cancer cells were transfected with CTRL or miR-29a mimics. 24hrs post-transfection, cells were treated with 25μM Chloroquine (CQ) for 3 hours and total protein was harvested. 5ug of total protein lysate was subjected to western blot analysis for p62 and LC3B quantification. GAPDH was used as loading control. Relative quantification of band intensities normalized to GAPDH are shown below respective blots. cells were treated with either 25μM Chloroquine (CQ) or 10μM BafilomycinA1 (BafA1) for 6hrs and lysed. 5ug of total protein lysate was subjected to western blot analysis for p62 and LC3B quantification. GAPDH was used as loading control. Relative quantification of band intensities normalized to GAPDH are shown below respective blots.
